Researches have confirmed that PELP1 had a diagnostic indicator for metastatic triple-negative breast cancer, and high expression of PELP1/Ki-67 in tumors was an independent prognostic factor for patients with triple-negative breast cancer (TNBC) (32, 33). Here, PELP1 is linked to triple-negative breast carcinoma.